Alzchem Group AG (ACT0.DE)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in EURTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | - | - | - | - | - | - | - | - |
| Operating profit | €m | - | |||||||
| Net profit | €m | - | - | - | - | - | - | - | - |
| EPS reported | € | - | |||||||
| Operating cashflow per share | € | - | |||||||
| Capex per share | € | - | |||||||
| FCF per share | € | - | |||||||
| Free cash flow | €m | - | |||||||
| Net debt | €m | - | |||||||
| Book value equity | €m | - | |||||||
| Book value per share | € | - | |||||||
| Number of shares | m | - | |||||||
| DPS (TTM paid) | € | - |
Financial summary
Financials in EURTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | |||||||
| P/B LTM | x | - | |||||||
| P/S LTM | x | - | |||||||
| P/FCF LTM | x | - | |||||||
| EV/EBITDA LTM | x | - | |||||||
| EV/Sales LTM | x | - | |||||||
| Earnings Yield LTM | % | - | |||||||
| FCF Yield | % | - | |||||||
| Quality | |||||||||
| ROE | % | - | |||||||
| ROIC | % | - | |||||||
| Operating margin | % | - | |||||||
| Gross margin | % | - | |||||||
| FCF/Sales | % | - | |||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | |||||||
| Sales Growth YoY | % | - | |||||||
| Net Income Growth YoY | % | - | |||||||
| FCF Growth | % | - | |||||||
| Operating Profit Growth | % | - | |||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | - | |||||||
| Dividend Growth | % | - | |||||||
| Payout Ratio | % | - | |||||||
| FCF/Debt | x | - | |||||||
| Net Debt/EBITDA | x | - | |||||||
| EBIT/Net interest | x | - | |||||||
| Net debt/market cap | % | - | |||||||
| Net debt/Equity | x | - | |||||||
| Gross debt/equity | x | - | |||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. It operates through the following segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment focuses on the production and distribution of growth products that contain specialty chemicals such as CreAMINO, Creapure, BioSelect, Silzot, DYHARD, and Dormex. The Basics & Intermediates segment covers the production of basic and intermediate products. The Other & Holding segment comprises services to the chemical parks in Trostberg and Hart. The company was founded on October 10, 1984 is headquartered in Trostberg, Germany.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Alzchem Group AG (ACT0.DE)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. It operates through the following segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment focuses on the production and distribution of growth products that contain specialty chemicals such as CreAMINO, Creapure, BioSelect, Silzot, DYHARD, and Dormex. The Basics & Intermediates segment covers the production of basic and intermediate products. The Other & Holding segment comprises services to the chemical parks in Trostberg and Hart. The company was founded on October 10, 1984 is headquartered in Trostberg, Germany.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free